Fabry disease is a multi-systemic, X-linked lysosomal storage disease caused by decreased activity of alpha-galactosidase A and results in lysosomal accumulations of neutral glycosphingolipids and globotriaosylceramide GL-3. This activity outlines the evaluation and management of Fabry disease and reviews the interprofessional team's role in improving care for patients with this condition.

**Objectives:**
- Describe the etiology of Fabry disease.
- Outline the presentation of a patient with Fabry disease.
- Review the management considerations of patients with Fabry disease.
- Summarize the importance of collaboration and communication amongst the interprofessional team members to enhance the delivery of care for patients affected by Fabry disease.